T-cell lymphoma, B-cell lymphoma, and myelodysplastic syndrome harboring common mutations: Trilineage tumorigenesis from a common founder clone.

angioimmunoblastic T‐cell lymphoma common mutations diffuse large B‐cell lymphoma founder clone multilineage tumorigenesis myelodysplastic syndrome

Journal

EJHaem
ISSN: 2688-6146
Titre abrégé: EJHaem
Pays: United States
ID NLM: 101761942

Informations de publication

Date de publication:
Feb 2022
Historique:
received: 10 07 2021
revised: 08 11 2021
accepted: 09 11 2021
entrez: 18 7 2022
pubmed: 19 7 2022
medline: 19 7 2022
Statut: epublish

Résumé

A 64-year-old man with angioimmunoblastic T-cell lymphoma (AITL) subsequently developed diffuse large B-cell lymphoma (DLBCL) and myelodysplastic syndrome (MDS). Genomic profiling of AITL, DLBCL, and MDS samples revealed that the tumor cells from all samples shared common mutations in

Identifiants

pubmed: 35846192
doi: 10.1002/jha2.354
pii: JHA2354
pmc: PMC9175790
doi:

Types de publication

Case Reports

Langues

eng

Pagination

211-214

Informations de copyright

© 2021 The Authors. eJHaem published by British Society for Haematology and John Wiley & Sons Ltd.

Déclaration de conflit d'intérêts

The authors declare that there is no conflict of interest that could be perceived as prejudicing theimpartiality of the research reported.

Références

Int J Hematol. 2016 Jun;103(6):627-33
pubmed: 26980223
Nat Genet. 2014 Apr;46(4):371-5
pubmed: 24584070
N Engl J Med. 2018 Sep 06;379(10):981-984
pubmed: 30184450
Blood. 2015 Oct 8;126(15):1741-52
pubmed: 26268241
Blood Adv. 2020 May 26;4(10):2261-2271
pubmed: 32442302
N Engl J Med. 2012 Jan 5;366(1):95-6
pubmed: 22216861
Blood. 2014 Feb 27;123(9):1293-6
pubmed: 24345752
Nat Genet. 2014 Feb;46(2):171-5
pubmed: 24413737
Blood Cancer J. 2017 Jan 6;7(1):e516
pubmed: 28157189
Blood. 2012 Feb 23;119(8):1901-3
pubmed: 22215888
Hematol Oncol. 2017 Dec;35(4):864-868
pubmed: 27353473
Blood. 2019 Apr 11;133(15):1664-1676
pubmed: 30782609
Br J Haematol. 2007 Sep;138(6):733-9
pubmed: 17672882
Leukemia. 2020 Oct;34(10):2592-2606
pubmed: 32704161
Nat Med. 2020 Oct;26(10):1549-1556
pubmed: 32747829
Oncogenesis. 2020 Aug 14;9(8):73
pubmed: 32796826
Leuk Lymphoma. 2019 Dec;60(13):3316-3319
pubmed: 31204875

Auteurs

Kyoko Yoshihara (K)

Department of Hematology Hyogo College of Medicine Hospital Nishinomiya Japan.

Yasuhito Nannya (Y)

Department of Pathology and Tumor Biology Kyoto University Kyoto Japan.

Ikuo Matsuda (I)

Department of Surgical Pathology Hyogo College of Medicine Nishinomiya Japan.

Mami Samori (M)

Department of Hematology Hyogo College of Medicine Hospital Nishinomiya Japan.

Nobuto Utsunomiya (N)

Department of Hematology Hyogo College of Medicine Hospital Nishinomiya Japan.

Masaya Okada (M)

Department of Hematology Hyogo College of Medicine Hospital Nishinomiya Japan.

Seiichi Hirota (S)

Department of Surgical Pathology Hyogo College of Medicine Nishinomiya Japan.

Seishi Ogawa (S)

Department of Pathology and Tumor Biology Kyoto University Kyoto Japan.

Satoshi Yoshihara (S)

Department of Hematology Hyogo College of Medicine Hospital Nishinomiya Japan.
Department of Transfusion Medicine and Cellular Therapy Hyogo College of Medicine Hospital Nishinomiya Japan.

Classifications MeSH